RO60 and interstitial lung disease: PF-ILD was detected in nine patients (CTD-ILD n = 4; IPAF n = 5) who did not receive antifibrotics including 44.4% with anti-SS-A positivity and 55.5% with post-exercise pulse increase, emphasizing the need for possible extension of antifibrotic treatment.